Novartis Investigative Site

Istanbul, Turkey 34304

0 studies enrolling now · 4 studies all time

What they study most

Acute Decompensated Heart Failure, Chronic Heart Failure, Congestive Heart Failure, Heart Failure With Reduced Ejection Fraction

Studies at this site

• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients — Completed
• Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure — Completed